These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18018502)

  • 21. Postprandial glucose and its role in type 2 diabetes.
    ; Davidson J; Gough S; Halimi S; Liebl A; Raskin P; Yan G
    Hormones (Athens); 2006; 5(3):1 p following 217. PubMed ID: 16955956
    [No Abstract]   [Full Text] [Related]  

  • 22. Fasting hyperglycemia predicts the magnitude of postprandial hyperglycemia: implications for diabetes therapy.
    Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
    Diabetes Care; 2002 Jul; 25(7):1247-8. PubMed ID: 12087032
    [No Abstract]   [Full Text] [Related]  

  • 23. Postprandial hyperglycaemia--the real challenge in diabetes.
    Jauhari J
    J Assoc Physicians India; 2002 Nov; 50():1456; author reply 1456. PubMed ID: 12583489
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of a new insulinotropic agent by using an innovative technology: efficacy and safety of nateglinide determined by continuous glucose monitoring.
    Abrahamian H; Francesconi M; Loiskandl A; Dzien A; Prager R; Weitgasser R
    Diabetes Technol Ther; 2004 Feb; 6(1):31-7. PubMed ID: 15000767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of structured self-monitoring of blood glucose improves glycemic control in real-world clinical practice: findings from a multinational and retrospectively controlled trial.
    Lalić N; Tankova T; Nourredine M; Parkin C; Schweppe U; Amann-Zalan I
    J Diabetes Sci Technol; 2013 Jan; 7(1):285-6. PubMed ID: 23439185
    [No Abstract]   [Full Text] [Related]  

  • 26. Postprandial and basal glucose in type 2 diabetes: assessment and respective impacts.
    Monnier L; Colette C; Owens D
    Diabetes Technol Ther; 2011 Jun; 13 Suppl 1():S25-32. PubMed ID: 21668334
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self monitoring of blood glucose in type 2 diabetes.
    Gulliford M
    BMJ; 2008 May; 336(7654):1139-40. PubMed ID: 18420661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring Glycemic Control.
    ; Berard LD; Siemens R; Woo V
    Can J Diabetes; 2018 Apr; 42 Suppl 1():S47-S53. PubMed ID: 29650111
    [No Abstract]   [Full Text] [Related]  

  • 29. What is the real contribution of fasting plasma glucose and postprandial glucose in predicting HbA(1c) and overall blood glucose control?
    Caputo S; Pitocco D; Ruotolo V; Ghirlanda G
    Diabetes Care; 2001 Nov; 24(11):2011. PubMed ID: 11679485
    [No Abstract]   [Full Text] [Related]  

  • 30. Glycemic risk factors of diabetic vascular complications: the role of glycemic variability.
    Zaccardi F; Pitocco D; Ghirlanda G
    Diabetes Metab Res Rev; 2009 Mar; 25(3):199-207. PubMed ID: 19172575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should postprandial glucose be routinely measured and treated to a particular target? No!
    Buse JB
    Diabetes Care; 2003 May; 26(5):1615-8. PubMed ID: 12716828
    [No Abstract]   [Full Text] [Related]  

  • 32. [How the continuous glucose monitoring system can contribute to HbA1c interpretation in type 1 diabetes mellitus?].
    Puñales MK; Geremia C; Mondadori P; Pickler M; Fornari A; Tschiedel B
    Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):299-306. PubMed ID: 18438540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contributions of Basal Glucose and Postprandial Glucose Concentrations to Hemoglobin A1c in the Newly Diagnosed Patients with Type 2 Diabetes--the Preliminary Study.
    Kang X; Wang C; Chen D; Lv L; Liu G; Xiao J; Yang Y; He L; Chen L; Li X; Tian H; Jia W; Ran X
    Diabetes Technol Ther; 2015 Jul; 17(7):445-8. PubMed ID: 25826625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes.
    Boland E; Monsod T; Delucia M; Brandt CA; Fernando S; Tamborlane WV
    Diabetes Care; 2001 Nov; 24(11):1858-62. PubMed ID: 11679447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical decision making: managing postprandial hyperglycemia.
    Hurel SJ; Mohan V
    J Assoc Physicians India; 2006 Nov; 54():871-6. PubMed ID: 17249256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of a patient education booklet (SimpleStart) effect on postprandial glucose control in type 2 diabetes.
    King AB; Wolfe GS; Armstrong DU
    Diabetes Technol Ther; 2007 Jun; 9(3):241-5. PubMed ID: 17561794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using meal-based self-monitoring blood glucose (SMBG) data to guide dietary recommendations in patients with diabetes.
    Jovanovic L
    Diabetes Educ; 2009; 35(6):1023-30. PubMed ID: 19934460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HgbA1c and glucose control: we cannot play it straight with patients.
    Hoogwerf BJ
    J Lab Clin Med; 2006 Jan; 147(1):5-6. PubMed ID: 16442999
    [No Abstract]   [Full Text] [Related]  

  • 39. Prandial glucose regulation in the glucose triad: emerging evidence and insights.
    Beisswenger P; Heine RJ; Leiter LA; Moses A; Tuomilehto J
    Endocrine; 2004 Dec; 25(3):195-202. PubMed ID: 15758245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SELF BLOOD GLUCOSE MONITORING UNDERESTIMATES HYPERGLYCEMIA AND HYPOGLYCEMIA AS COMPARED TO CONTINUOUS GLUCOSE MONITORING IN TYPE 1 AND TYPE 2 DIABETES.
    Mangrola D; Cox C; Furman AS; Krishnan S; Karakas SE
    Endocr Pract; 2018 Jan; 24(1):47-52. PubMed ID: 29144814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.